Solve patient compliance
As Convenient as Prescribing Eye Drops
Ease of Use
Intuitive Set Up and Functionality
Treat More Patients
Improve Access to Care
DSLT has serious potential to transform the way we manage glaucoma, providing a real solution to compliance issues. The device is efficient, non-contact, and offers safe and efficacious glaucoma treatment with just the press of a button.
There are many advantages to the device: it is non-contact and patients do not need the same degree of anesthesia as in other treatments or an invasive lens implanted into the eye. One of the most significant advantages is that it is automated and efficient which broadens the scope of who can perform and receive the treatment.
DSLT is a great option for my patients. It’s painless and more comfortable for patients, quick to learn for surgeons, and, therefore, more accessible to ophthalmologists. For me, it’s the promise of a truly patient-friendly, effective procedure that should draw the interests of ophthalmologists to this new form of laser trabeculoplasty.
I believe this is a disruptive technology which will allow us to help doctors feel more comfortable using laser as a first line treatment.
A practice-changing technology allowing you to treat your patients efficiently and effectively.
Status: Completed 2014
Number of Patients: 28
Primary Endpoint: IOP reduction at 6 monthsRead more
Status: Completed 2019
Number of Patients: 15
Primary Endpoint: IOP reduction at 3 monthsRead more
Status: Enrollment Complete
Number of Patients: 192
Primary Endpoint: IOP reduction at 6 months
Follow-up: 12 monthsRead more
2022 Journal of Glaucoma
Radcliffe N, et al.Read More
2021 TVST – ARVO Journal
Goldenfeld M, et al.Read More
2020 Biomedial Optics Express
Sacks Z, et al.Read More
Subscribe to receive BELKIN Vision's Newsletter with the latest news and clinical updates.